IDO1-IN-37
IDO1/TDO-IN-13 (Compound 40) is a selective, non-competitive IDO1 inhibitor with an IC50 of 0.106 μM against IDO1. IDO1/TDO-IN-13 is applicable to the research of inflammatory diseases.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 3117126-69-6
- Formel: C13H6Cl2FNO2S
- Molecular Weight:330.16
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biologische Aktivität
Beschreibung
IC50 & Target
[1]|
IDO1 0.106 μM (IC50) |
In Vitro
IDO1/TDO-IN-13 (45 min) potently inhibits recombinant IDO1 with an IC50 of 0.106 μM; it also inhibits recombinant TDO2 with an IC50 of 6.91 μM[1].
IDO1/TDO-IN-13 (48 h) inhibits IDO1 activity in IFN-γ-stimulated BxPC-3 cells, with an IC50 of 5.09 μM[1].
IDO1/TDO-IN-13 (0-1.0 μM; 45 min) acts as a non-competitive inhibitor of recombinant IDO1 against D-tryptophan (HY-W012479)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
CAS. Nr. 3117126-69-6
-
Molecular Weight 330.16
-
Formel C13H6Cl2FNO2S
-
SMILES
ClC1=CC=C(C=C1)S(C2=NC3=C(O2)C=C(Cl)C(F)=C3)=O
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Protokoll
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)